Peptide MS/MS Sequence Coverage: What Fragment Ions Establish

Peptide MS/MS sequence coverage describes how fragmentation data support a proposed sequence. A high coverage percentage can be useful, but the percentage alone does not show whether the most important sequence positions were distinguished. Two reports with similar coverage may answer different analytical questions.

A careful review connects the annotated spectrum to the proposed molecule. It identifies what is directly supported, where assignments depend on assumptions, and which uncertainties remain after the experiment.

Begin with the fragmentation method

MS/MS isolates and fragments selected precursor ions, then measures product ions. The Matrix Science fragmentation reference explains common ion families: b-type ions retain the N-terminal side, while y-type ions retain the C-terminal side. The ion types and abundances depend on the fragmentation conditions.

Consequently, a report should identify the acquisition approach and the precursor charge. An annotation scheme appropriate to one fragmentation method should not be transferred automatically to another.

Begin the review with the expected sequence, terminal groups, modifications, and precursor assignment. Otherwise, even a detailed ion table can describe the wrong molecular hypothesis.

Look beyond the percentage

Ask how the software defines coverage. Does it count supported backbone cleavage positions, matched residues, or another measure? Are complementary ion families combined? Does the summary conceal a long unsupported region?

In a hypothetical comparison between two candidate sequences, most observed fragments might be shared by both candidates. High overall coverage would not resolve the specific difference if the distinguishing region were unsupported.

Mark the positions that matter to the question before evaluating the headline percentage. The useful result is evidence that addresses those positions, not simply the largest count of colored annotations.

Assess assignments rather than accepting labels

For important fragments, review the observed and expected m/z, assigned charge, mass tolerance, and signal context. Consider whether several labels compete for the same peak or whether the selected ion family fits the instrument method.

Original research on collision energy and b- and y-ion response showed that fragmentation behavior depends on the transition and acquisition conditions. A missing ion therefore requires context; its absence is not a universal rule against the sequence.

Preserve the raw spectrum and search settings with the annotation export. A static image with labels is less useful when a reviewer cannot reconstruct how those labels were assigned.

Keep structural limitations visible

Conventional backbone fragment information does not resolve every chemical distinction. For example, common b/y mass assignments alone do not distinguish leucine from isoleucine. Specialized evidence may be needed when that distinction is central.

Similarly, an intact precursor match and a plausible series of fragments should not silently establish every modification location, stereochemical assignment, or linkage. The conclusion should describe the evidence actually obtained.

Use the site's sequence specification guide to keep the intended molecular form explicit. The analytical report can then state which elements of that specification were tested.

Write an evidence-centered conclusion

A useful review records the candidate sequence, supported regions, unresolved alternatives, and the reason any additional work is needed. If a distinguishing fragment is missing, specify that gap rather than asking vaguely for “better testing.”

For a hypothetical report, a clear conclusion might be that the data support the expected backbone over the observed region while leaving one modification position unresolved. That is more useful for planning than calling the entire molecule confirmed without qualification.

When requesting available documentation, contact Peptide Wholesale Supply with the exact item and analytical question. Confirm whether the supplied records include MS/MS information; its presence should not be assumed from a general identity statement.

Related reading

Continue with Monoisotopic vs Average Peptide Mass: Comparing the Right Numbers; Disulfide Mapping in Peptide Research: Testing Cysteine Connectivity; D- and L-Amino Acids in Peptides: Evaluating Chiral Analysis.

For in vitro laboratory research use only. Not for human or animal use or consumption. Not for diagnostic or therapeutic use.